TetraGraph in Rocuronium Infusions
Not Applicable
Not yet recruiting
- Conditions
- Surgery
- Interventions
- Device: TetraGraph
- Registration Number
- NCT06472284
- Lead Sponsor
- Joseph D. Tobias
- Brief Summary
This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patients less than 18 years of age
- American Society of Anesthesiologists classification (ASA) 1-4
- Patients undergoing a surgical procedure with general anesthesia and requiring the continuous administration of rocuroniuim
Read More
Exclusion Criteria
- Patients less than 28 days old
- Patients with history of a progressive or degenerative peripheral neurologic or neuropathic disorder
- Patients undergoing a surgical procedure in which neuromuscular blockade is not required
- Edematous patients
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Rocuronium infusion TetraGraph Patients who are scheduled for elective, urgent or emergent surgery requiring the continuous infusion of the neuromuscular blocking agent, rocuronium.
- Primary Outcome Measures
Name Time Method EMG changes During the surgery (2-8 hrs.) Changes in the amplitude of the evoked response of the muscles
Maximum dose of rocuronium During the surgery (2-8 hrs.) The maximum dose of rocuronium administered by a continuous infusion to maintain one twitch of the train of four (TOF)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Nationwide Children's Hospital
🇺🇸Columbus, Ohio, United States